Lining Wang
Ruijin Er Road 197
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Unexpected renal influence on isavuconazole trough concentrations: two case reports and literature review.
Journal: Frontiers in medicine
Published: May 12, 2025
Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1α.
Journal: Leukemia
Published: January 20, 2025
Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxis.
Journal: Bone marrow transplantation
Published: April 30, 2024
Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning.
Journal: Bone marrow transplantation
Published: December 11, 2023
Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 17, 2023
A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.
Journal: Cell reports. Medicine
Published: March 24, 2023
Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα.
Journal: Cell death and differentiation
Published: July 01, 2022
Cladribine-based debulking chemotherapy sequential with reduced intensity regimen and post-transplantation maintenance for refractory myeloid leukemia: a prospective phase II clinical trial.
Journal: Bone marrow transplantation
Published: December 18, 2021
Clinical Significance of Haplo-Fever and Cytokine Profiling After Graft Infusion in Allogeneic Stem Cell Transplantation From Haplo-Identical Donors.
Journal: Frontiers in medicine
Published: November 23, 2021
Optimization of idarubicin and cytarabine induction regimen with homoharringtonine for newly diagnosed acute myeloid leukemia patients based on the peripheral blast clearance rate: A single-arm, phase 2 trial (RJ-AML 2014).
Journal: American journal of hematology
Published: August 21, 2021
Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Journal: Chemotherapy
Published: March 06, 2021
Last Updated: 09/26/2026